Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma

[url="]Natera, Inc.[/url] (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new collaboration with Diakonos Oncology C